At least four states have expanded eligibility for Covid-19 booster shots to everyone 18 and older, six months after their second dose, even though the FDA hasn't done so yet and the CDC hasn't given its recommendation.
Some states are not waiting. At least four so far -- Arkansas, California, Colorado, New Mexico and West Virginia -- have expanded eligibility for Covid-19 booster shots to everyone 18 and older, six months after their second dose, even though the US Food and Drug Administration hasn't done so yet and the US Centers for Disease Control and Prevention hasn't given its recommendation.
So far, the federal health agencies have only given the green light for Pfizer/BioNTech and Moderna boosters to be administered to adults ages 65 and older or any adults at high risk of severe Covid-19 or who live or work in long-term care settings or high-risk settings who completed their second dose at least six months ago. All adults who have received the Johnson & Johnson vaccine at least two months ago are eligible for boosters.But that could soon change.
Public health officials in the Biden administration are on the"same page" when it comes to the benefits of booster shots, US Surgeon General Dr. Vivek Murthy said Sunday."The reality is that there is much more agreement here than I think people appreciate," said Murthy when asked by Fox News' Chris Wallace whether there was a split among experts like Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, and CDC Director Dr.
Australia Latest News, Australia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Covid-19: Booster jabs for over-40s and Northern Ireland considers Covid passportsFive things you need to know about the coronavirus pandemic this Monday evening.
Read more »
Pfizer Seeks FDA Emergency Use Authorization for Its COVID-19 PillPfizer has signed a deal to allow other manufacturers to make its experimental COVID-19 pill, possibly opening up access to treatment to countries across the world:
Read more »
Pfizer seeks FDA emergency use authorization for its experimental Covid-19 antiviral pillPfizer announced Tuesday that it is seeking emergency use authorization from the US Food and Drug Administration for its experimental antiviral Covid-19 pill, known as PF-07321332 or Paxlovid.
Read more »
FDA expected to authorize Pfizer COVID-19 booster for all adults this weekThe move could come as early as Thursday.
Read more »
Which states have opened COVID-19 vaccine boosters for all?A growing list of states are now moving ahead of federal authorization, recommending booster shots for all residents 18 years or older, six months after receiving their second COVID vaccine dose.
Read more »